PTK2 and cancer: This relationship was further supported by the demonstration that CD133 phosphorylated on tyrosine Y852 interacted with Src, leading to Src activation and subsequent formation of a Src-FAK complex which stimulates the invasive behavior of these cancer cells (Fig. 7b) [352].